SS
BBLG

SBI Securities’s Bone Biologics BBLG Stock Holding History

SBI Securities’s Portfolio BBLG Stock Details BBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315 Hold
230
– – ﹤0.01% 3185
2026
Q1 		$253 Hold
230
– – ﹤0.01% 3130
2025
Q4 		$334 Hold
230
– – ﹤0.01% 3024
2025
Q3 		$642 Buy
+230
New +$583 ﹤0.01% 2874
2025
Q2 		– Hold
0
– -$1 – 4149
2025
Q1 		– Hold
0
– – – 4107
2024
Q4 		– Hold
0
– – – 4072

SBI Securities's BBLG Position: Q2 2026 in Review

SBI Securities held its Bone Biologics (BBLG) position steady in Q2 2026 at 230 shares worth $315. The position accounts for ﹤0.01% of the portfolio, ranked #3185.

SBI Securities first reported a position in BBLG in Q3 2025 and has held it in 4 quarters since. The position peaked at $642 in Q3 2025. 1 fund tracked by Wall St. Rank holds BBLG as of Q2 2026.

  • SBI Securities held 230 shares of Bone Biologics worth $315 as of Q2 2026.
  • SBI Securities left its Bone Biologics share count unchanged in Q2 2026.
  • Bone Biologics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3185 holding.
  • SBI Securities first reported a position in Bone Biologics in Q3 2025 and has held it in 4 quarters since.
  • SBI Securities's Bone Biologics position peaked at $642 in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Bone Biologics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.